Director Declaration

RNS Number : 5598M
Medica Group PLC
12 January 2023
 

12 January 2023

 

Medica Group Plc

 

Director Declaration

 

Medica Group Plc (LSE:MGP, "Medica"), the UK market leader in the provision of teleradiology services, announces that Barbara Moorhouse, Non-Executive Director and Chair of the Audit Committee of Medica, has been appointed a non-executive director of Glas Cymru Holdings Cyf, the owner of water company, Dwr Cymru (Welsh Water), with effect from 16 January 2023.

 

For further information, please contact:

 

Medica Group Plc:

Stuart Quin, Chief Executive Officer

Richard Jones, Chief Financial Officer

 

+44 (0)33 33 111 222

 

FTI Consulting

Victoria Foster Mitchell

Sam Purewal

 

 

+44 (0)20 3727 1000

Liberum (Joint Broker)

Phil Walker

Richard Lindley

 

+44 (0)20 3100 2000

Numis (Joint Broker)

Freddie Barnfield

Duncan Monteith

Euan Brown

 

+44 (0)20 7260 1000

 

 

About Medica Group PLC

 

Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting.

In Ireland, Medica carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening programme for the National Screening Service. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials.

For more information please visit:  www.medicagroupplc.com  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBBGDBDBBDGXD

Companies

Medica Group (MGP)
UK 100